Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0OH1O
|
||||
Former ID |
DIB016031
|
||||
Drug Name |
VULM-1457
|
||||
Synonyms |
Acyl CoA cholesterol acyltransferase inhibitor (dyslipidemia/atherosclerosis), Univerzity Komenskeho v Bratislave
|
||||
Indication | Atherosclerosis [ICD9: 414.0, 440; ICD10:I70] | Investigative | [1] | ||
Company |
Univerzity Komenskeho v Bratislave
|
||||
Structure |
![]() |
Download2D MOL |
|||
Canonical SMILES |
c1(NC(=O)Nc2ccc(Sc3ccc([N+](=O)[O-])cc3)cc2)c(C(C)C)ccc<br />c1C(C)C
|
||||
Target and Pathway | |||||
Target(s) | Liver carboxylesterase | Target Info | Inhibitor | [1] | |
KEGG Pathway | Drug metabolism - other enzymes | ||||
Metabolic pathways | |||||
Pathway Interaction Database | E2F transcription factor network | ||||
WikiPathways | NRF2 pathway | ||||
Nuclear Receptors Meta-Pathway | |||||
Heroin metabolism | |||||
Irinotecan Pathway | |||||
Fluoropyrimidine Activity | |||||
Phase I biotransformations, non P450 | |||||
References | |||||
REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2592). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.